Cooperative Studies Scientific Evaluation Committee; Notice of Meeting, 89054-89055 [2023-28377]
Download as PDF
<![CDATA[
89054
Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices
TABLE 2—TAXPAYER BURDEN FOR ENTITIES TAXED AS TAXABLE CORPORATIONS
Total number
of returns
(in millions)
Primary form filed or type of taxpayer
All Taxable Corporations .................................................................................
Small ................................................................................................................
Large * ..............................................................................................................
Average time
(hrs.)
2.1
2.0
0.1
105
55
830
Average outof-pocket cost
Average monetized burden
$6,700
3,600
53,800
$14,900
6,200
149,000
Forms 1120, 1120–C, 1120–F, 1120–H, 1120–ND, 1120–SF, 1120–FSC, 1120–L, 1120–PC, 1120–POL and all attachments
TABLE 3—TAXPAYER BURDEN FOR ENTITIES TAXED AS PASS-THROUGH CORPORATIONS
Total number
of returns
(in millions)
Primary form filed or type of taxpayer
All Pass-through Corporations .........................................................................
Small ................................................................................................................
Large * ..............................................................................................................
Average time
(hrs.)
5.8
5.7
0.1
65
60
295
Average outof-pocket cost
Average monetized burden
$4,400
3,800
37,700
$7,500
6,400
71,800
Forms 1120–REIT, 1120–RIC, 1120–S and all attachments
Source: IRS: RAAS:KDA:TBL (12–1–23)
* A large business is defined as one having end-of-year assets greater than $10 million. Total filers counts may not equal the burden total estimates table due to rounding.
FY2024
Total
positive
income
Average
time (hrs.)
Average
out-of-pocket
costs
Average
monetized
burden
Table 1A—Taxpayer Burden for Taxable Corporations on Form 1120
1.
2.
3.
4.
5.
< 100k ....................................................................................................................................
100k to 1mil ...........................................................................................................................
1mil to 10mil ..........................................................................................................................
10mil to 100mil ......................................................................................................................
> 100mil .................................................................................................................................
42
63
113
546
4,398
1,330
4,323
12,359
43,055
220,425
1,987
6,916
24,573
105,788
725,848
1,564
3,814
9,595
36,698
148,905
2,338
6,015
17,797
69,606
286,533
1,627
4,601
12,960
46,258
190,307
2,530
7,501
23,196
83,805
356,260
Table 2A—Taxpayer Burden for Pass-through Corporations on Form 1120S
1.
2.
3.
4.
5.
< 100k ....................................................................................................................................
100k to 1mil ...........................................................................................................................
1mil to 10mil ..........................................................................................................................
10mil to 100mil ......................................................................................................................
> 100mil .................................................................................................................................
52
59
79
287
1,200
Table 3A—Taxpayer Burden for Partnerships on Form 1065
1.
2.
3.
4.
5.
< 100k ....................................................................................................................................
100k to 1mil ...........................................................................................................................
1mil to 10mil ..........................................................................................................................
10mil to 100mil ......................................................................................................................
> 100mil .................................................................................................................................
45
56
93
327
1,447
Source: IRS: RAAS: KDA:TBL (12–1–23).
Detail may not add to total due to rounding.
Authority: 44 U.S.C. 3501 et seq.
Melody Braswell,
Treasury PRA Clearance Officer.
[FR Doc. 2023–28446 Filed 12–22–23; 8:45 am]
khammond on DSKJM1Z7X2PROD with NOTICES
BILLING CODE 4830–01–P
DEPARTMENT OF VETERANS
AFFAIRS
Cooperative Studies Scientific
Evaluation Committee; Notice of
Meeting
The Department of Veterans Affairs
(VA) gives notice under the Federal
Advisory Committee Act, 5 U.S.C. ch.
10, that the Cooperative Studies
Scientific Evaluation Committee
(CSSEC) will hold a meeting on January
18, 2024, via Zoom from 1–4 p.m. EST.
VerDate Sep<11>2014
20:25 Dec 22, 2023
Jkt 262001
PO 00000
Frm 00191
Fmt 4703
Sfmt 4703
The Committee provides expert
advice on VA cooperative studies,
multi-site clinical research activities
and policies related to conducting and
managing these efforts. The session will
be open to the public for the first 30
minutes of the meeting (approximately)
for the discussion of administrative
matters and the general status of the
program. The remaining portion of the
meeting will be closed to the public for
the Committee’s review, discussion and
evaluation of research and development
applications.
E:\FR\FM\26DEN1.SGM
26DEN1
Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
During the closed portion of the
meeting, the Committee’s discussions
and recommendations will address the
qualifications of the personnel
conducting the studies; staff and
consultant critiques of research
proposals and similar documents; and
the medical records of study subjects,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Additionally, premature disclosure of
research information to the public could
significantly obstruct implementation of
VerDate Sep<11>2014
20:25 Dec 22, 2023
Jkt 262001
approved research activities. As
provided by Public Law 92–463
subsection 10(d), and amended by
Public Law 94–409, closing the
Committee meeting is in accordance
with 5 U.S.C. 552b(c)(6) and (9)(B).
The Committee will accept oral
comments from the public for the open
portion of the meeting. Members of the
public who wish to attend the open
teleconference should call 872–701–
0185, conference ID 456 277 285#.
Those who plan to attend or would like
additional information should contact
PO 00000
Frm 00192
Fmt 4703
Sfmt 9990
89055
David Burnaska, Program Manager,
Cooperative Studies Program (14RD),
Department of Veterans Affairs, 810
Vermont Avenue NW, Washington, DC
20420, at David.Burnaska@va.gov.
Those wishing to submit written
comments may send them to Mr.
Burnaska at the same address and email.
Dated: December 20, 2023.
LaTonya L. Small,
Federal Advisory Committee Management
Officer.
[FR Doc. 2023–28377 Filed 12–22–23; 8:45 am]
BILLING CODE P
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 88, Number 246 (Tuesday, December 26, 2023)]
[Notices]
[Pages 89054-89055]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28377]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Cooperative Studies Scientific Evaluation Committee; Notice of
Meeting
The Department of Veterans Affairs (VA) gives notice under the
Federal Advisory Committee Act, 5 U.S.C. ch. 10, that the Cooperative
Studies Scientific Evaluation Committee (CSSEC) will hold a meeting on
January 18, 2024, via Zoom from 1-4 p.m. EST.
The Committee provides expert advice on VA cooperative studies,
multi-site clinical research activities and policies related to
conducting and managing these efforts. The session will be open to the
public for the first 30 minutes of the meeting (approximately) for the
discussion of administrative matters and the general status of the
program. The remaining portion of the meeting will be closed to the
public for the Committee's review, discussion and evaluation of
research and development applications.
[[Page 89055]]
During the closed portion of the meeting, the Committee's
discussions and recommendations will address the qualifications of the
personnel conducting the studies; staff and consultant critiques of
research proposals and similar documents; and the medical records of
study subjects, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy. Additionally, premature
disclosure of research information to the public could significantly
obstruct implementation of approved research activities. As provided by
Public Law 92-463 subsection 10(d), and amended by Public Law 94-409,
closing the Committee meeting is in accordance with 5 U.S.C. 552b(c)(6)
and (9)(B).
The Committee will accept oral comments from the public for the
open portion of the meeting. Members of the public who wish to attend
the open teleconference should call 872-701-0185, conference ID 456 277
285#. Those who plan to attend or would like additional information
should contact David Burnaska, Program Manager, Cooperative Studies
Program (14RD), Department of Veterans Affairs, 810 Vermont Avenue NW,
Washington, DC 20420, at [email protected]. Those wishing to submit
written comments may send them to Mr. Burnaska at the same address and
email.
Dated: December 20, 2023.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2023-28377 Filed 12-22-23; 8:45 am]
BILLING CODE P
